These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 15174468

  • 1. [New treatment options for HIV-infected patients].
    Wehr A.
    Dtsch Med Wochenschr; 2004 May 07; 129(19):1093. PubMed ID: 15174468
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 96-week CASTLE data show similar efficacy results.
    AIDS Patient Care STDS; 2008 Nov 07; 22(11):918. PubMed ID: 19043840
    [No Abstract] [Full Text] [Related]

  • 7. A king in the CASTLE? Optimum initial HIV protease inhibitor.
    Torti C, Frank I.
    Lancet; 2008 Aug 23; 372(9639):604-6. PubMed ID: 18722849
    [No Abstract] [Full Text] [Related]

  • 8. Lopinavir + ritonavir tablets: new formulation. More convenient, but minimal evaluation.
    Prescrire Int; 2007 Aug 23; 16(90):148. PubMed ID: 17724839
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Atazanavir protects lipid metabolism. New PI with favorable metabolic profile].
    MMW Fortschr Med; 2004 Apr 26; 146 Spec No 1():90. PubMed ID: 15373065
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Efficacy of atazanavir in simplification regimens].
    Zamora L, Gatell JM.
    Enferm Infecc Microbiol Clin; 2008 Dec 26; 26 Suppl 17():14-21. PubMed ID: 20116612
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy of atazanavir in treatment-naive patients].
    Moreno S, Hernández B, Dronda F.
    Enferm Infecc Microbiol Clin; 2008 Dec 26; 26 Suppl 17():9-13. PubMed ID: 20116611
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial.
    Soriano V, García-Gasco P, Vispo E, Ruiz-Sancho A, Blanco F, Martín-Carbonero L, Rodríguez-Novoa S, Morello J, de Mendoza C, Rivas P, Barreiro P, González-Lahoz J.
    J Antimicrob Chemother; 2008 Jan 26; 61(1):200-5. PubMed ID: 17999977
    [Abstract] [Full Text] [Related]

  • 17. Anti-HIV agents. Lopinavir and ritonavir (Kaletra) tablets get tested.
    TreatmentUpdate; 2008 Mar 26; 20(2):5-6. PubMed ID: 18661644
    [No Abstract] [Full Text] [Related]

  • 18. Hepatitis coinfection and LPV/RTV.
    Carter M.
    IAPAC Mon; 2004 Oct 26; 10(10):398. PubMed ID: 15801120
    [No Abstract] [Full Text] [Related]

  • 19. Anti-HIV agents. Monotherapy studies--points to consider.
    TreatmentUpdate; 2008 Jan 26; 20(1):3-4. PubMed ID: 18320692
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.